homefeedbacksupportlog on 4-Jul-2009 
  About F1000

 What is F1000?
 Key features
 How it's organized
 FAQs
 Faculties and sections
 Scope of sections
 Intl Advisory Board
 List of Faculty Members
 Associate Faculty Members
 The evaluation system
 Citing F1000
 Take a tour of the site
 Accessing fulltexts
 PubMed linkout
 How to subscribe
 Academic subscriptions
 Corporate subscriptions
 Try F1000 for free
 Who we are
 Media information
 Librarian resources
 Press releases
 In the press
 Developing countries
 F1000 Medicine
 Terms and conditions
 Privacy policy
 Contact us


Michael Cunningham
Laboratory of Pharmacology and Chemistry,, NIEHS, NIH, Research Triangle Park,, United States of America

Faculty Member: Pharmacology & Drug Discovery > Toxicology [ since 29 June 2006 ]
[ Biography ] [ Homepage ] [ Evaluations ]
Biography

Michael L. Cunningham, Ph.D.
University of Arizona, Pharmacology and Toxicology, 1981.

Host Susceptibility Branch
National Toxicology Program
National Institutes of Health
National Institute of Environmental Health Science
Research Triangle Park, North Carolina
USA

Recent advances in genomic, metabonomic and proteomic research, coupled with the availability of novel tools and methods to analyze the products of altered gene expression, have provided new insights into mechanisms of toxicity evoked by xenobiotics. While these advances promise to revolutionize our ability to characterize hazard, the challenge in the near future is to establish a body of available knowledge to serve as a foundation for applying the data generated by these new methods to risk assessment. Toxicogenomics is a powerful tool for improving human risk assessment because it will measure specific changes in gene expression in humans and other species that are exposed to drugs or other agents and to profile the process of disease progression. Careful data analysis could identify similar patterns in different species, leading to a "signature" for a given pathway of toxicity or disease state in humans. Once signatures are identified using large scale, global microarray analysis, it will then be possible to develop smaller, multi-chemical and multi-pathway arrays that can be used to assess the potential toxicity of chemicals in a rapid, prospective manner. This would result in better interspecies extrapolation, greater confidence in animal models, reduction in the number of animals needed for testing, faster testing, and most importantly, insights into pathways of toxicity and disease processes and their mechanisms heretofore unattainable using less developed technologies.

Home page

http://devwww.niehs.nih.gov/research/atniehs/labs/hsb/staff/cunningham/index.cfm

to email [Help]
Evaluations

Mouse population-guided resequencing reveals that variants in CD44 contribute to acetaminophen-induced liver injury in humans.
Harrill AH, Watkins PB, …, Rusyn I, Threadgill DW
Genome Res 2009 May 5 [abstract on PubMed] [related articles] [full text]
Selected by | Michael Cunningham
Evaluated 1 Jun 2009

Discovery of metabolomics biomarkers for early detection of nephrotoxicity.
Boudonck KJ, Mitchell MW, …, Shinar D, Rosenstock M
Toxicol Pathol 2009 37(3):280-92 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Michael Cunningham
Evaluated 13 May 2009

Gene expression analysis reveals new possible mechanisms of vancomycin-induced nephrotoxicity and identifies gene markers candidates.
Dieterich C, Puey A, …, Mirsalis JC, Ng HH
Toxicol Sci 2009 Jan 107(1):258-69 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Michael Cunningham
Evaluated 22 Jan 2009

Metabolomic profiling of a modified alcohol liquid diet model for liver injury in the mouse uncovers new markers of disease.
Bradford BU, O'Connell TM, …, Kono H, Rusyn I
Toxicol Appl Pharmacol 2008 Jul 12 232 [abstract on PubMed] [related articles] [full text]
Selected by | Michael Cunningham
Evaluated 16 Oct 2008

Transcriptomic Analysis of Nephrotoxicity Induced by Cephaloridine, a Representative Cephalosporin Antibiotic.
Rokushima M, Fujisawa K, …, Ishizaki J, Omi K
Chem Res Toxicol 2008 May 23 21 [abstract on PubMed] [related articles] [full text]
Selected by | Michael Cunningham
Evaluated 10 Jul 2008

In vitro metabolism of a model cyclopropylamine to reactive intermediate: insights into trovafloxacin-induced hepatotoxicity.
Sun Q, Zhu R, Foss FW, Macdonald TL
Chem Res Toxicol 2008 Mar 21(3):711-9 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Michael Cunningham
Evaluated 24 Apr 2008

Trovafloxacin-induced gene expression changes in liver-derived in vitro systems: comparison of primary human hepatocytes to HepG2 cells.
Liguori MJ, Blomme EA, Waring JF
Drug Metab Dispos 2008 Feb 36(2):223-33 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Michael Cunningham
Evaluated 12 Feb 2008

Gene expression profiling reveals underlying molecular mechanisms of the early stages of tamoxifen-induced rat hepatocarcinogenesis.
Pogribny IP, Bagnyukova TV, …, Ross SA, Beland FA
Toxicol Appl Pharmacol 2007 Nov 15 225(1):61-9 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Michael Cunningham
Evaluated 30 Nov 2007

S-nitrosohemoglobin deficiency: a mechanism for loss of physiological activity in banked blood.
Reynolds JD, Ahearn GS, …, Cobb F, Stamler JS
Proc Natl Acad Sci U S A 2007 Oct 23 104(43):17058-62 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Michael Cunningham
Evaluated 24 Oct 2007


Hepatoprotective role of endogenous interleukin-13 in a murine model of acetaminophen-induced liver disease.
Yee SB, Bourdi M, Masson MJ, Pohl LR
Chem Res Toxicol 2007 May 20(5):734-44 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Michael Cunningham
Evaluated 20 Aug 2007

Troglitazone-induced hepatic necrosis in an animal model of silent genetic mitochondrial abnormalities.
Ong MM, Latchoumycandane C, Boelsterli UA
Toxicol Sci 2007 May 97(1):205-13 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Michael Cunningham
Evaluated 21 May 2007


Prediction of in vivo potential for metabolic activation of drugs into chemically reactive intermediate: correlation of in vitro and in vivo generation of reactive intermediates and in vitro glutathione conjugate formation in rats and humans.
Masubuchi N, Makino C, Murayama N
Chem Res Toxicol 2007 Mar 20(3):455-64 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Michael Cunningham
Evaluated 16 Apr 2007

A toxicogenomic approach revealed hepatic gene expression changes mechanistically linked to drug-induced hemolytic anemia.
Rokushima M, Omi K, …, Kato I, Ishizaki J
Toxicol Sci 2007 Feb 95(2):474-84 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Michael Cunningham
Evaluated 1 Feb 2007

Identification of potential genomic biomarkers of hepatotoxicity caused by reactive metabolites of N-methylformamide: Application of stable isotope labeled compounds in toxicogenomic studies.
Mutlib A, Jiang P, …, Madore S, Nelson S
Chem Res Toxicol 2006 Oct 19(10):1270-83 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Michael Cunningham
Evaluated 15 Jan 2007

Alterations in the rat serum proteome during liver injury from acetaminophen exposure.
Merrick BA, Bruno ME, …, Taylor J, Tomer KB
J Pharmacol Exp Ther 2006 Aug 318(2):792-802 [abstract on PubMed] [related articles] [FREE full text]
Selected by | Michael Cunningham
Evaluated 16 Oct 2006

Systems toxicology: integrated genomic, proteomic and metabonomic analysis of methapyrilene induced hepatotoxicity in the rat.
Craig A, Sidaway J, …, Wilson I, Nicholson J
J Proteome Res 2006 Jul 5(7):1586-601 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Jonathan Sweedler / Michael Cunningham
Evaluated 14 Sep 2006

A system-based approach to interpret dose- and time-dependent microarray data: quantitative integration of gene ontology analysis for risk assessment.
Yu X, Griffith WC, …, Vredevoogd MA, Faustman EM
Toxicol Sci 2006 Aug 92(2):560-77 [abstract on PubMed] [related articles] [FREE full text]
Selected by | Michael Cunningham
Evaluated 26 Jul 2006

^Top  Back to Faculty Members



© 1999-2009 Biology Reports Ltd unless otherwise stated. < info@f1000.com >   Terms and conditions   Legal info